The Inflation Reduction Act is a Foot in the Door for Containing Health Care Costs
In this JAMA Forum column, KFF’s Larry Levitt examines the Medicare drug-price negotiation provisions and other drug-price reforms in the Inflation Reduction Act and their potential to spur others efforts to address health care costs.